Innovex International (INVX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Voting matters and shareholder proposals
Election of three director nominees—John Lovoi, Will Donnell, and Angie Sedita—for a three-year term is up for vote.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 is proposed.
Advisory vote on executive compensation (say-on-pay) is included as a non-binding proposal.
Additional business may be transacted as appropriate during the meeting or any reconvened session.
Board of directors and corporate governance
Board recommends voting in favor of all three main proposals presented at the annual meeting.
Director nominees are identified by name and proposed for a three-year term.
Executive compensation and say-on-pay
Shareholders will conduct a non-binding advisory vote to approve named executive officer compensation.
Latest events from Innovex International
- Proxy covers director elections, auditor ratification, and executive pay, with strong governance focus.INVX
Proxy filing27 Mar 2026 - Q4 revenue up 14% sequentially, strong cash flow, and margin expansion expected in 2026.INVX
Q4 202524 Feb 2026 - Q3 revenue up 17% to $152M; $83M net income and $15M synergies highlight merger impact.INVX
Q3 202415 Jan 2026 - Post-merger registration allows resale of 44% of shares, with no proceeds to the company.INVX
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, share increase, LTIP, auditor, and executive pay.INVX
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, share increase, LTIP, auditor, and say-on-pay votes.INVX
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, share increase, incentives, auditor, and pay.INVX
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 58% YoY to $240M, with strong cash flow and major acquisitions completed.INVX
Q3 202513 Nov 2025 - Q2 2025 revenue surged 72% YoY to $224.2M, fueled by acquisitions and global expansion.INVX
Q2 20256 Aug 2025